CSF neurofilament light levels predict hippocampal atrophy in cognitively healthy older adults.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Neurobiology of Aging

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.neurobiolaging.2016.09.012PMID 27794264
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of amyloid-PET to determine cutpoints for CSF markers

  2016cited by this paper
• Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer’s Disease

  2016cited by this paper
• Suspected non-Alzheimer disease pathophysiology — concept and controversy

  2016cited by this paper
• CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.

  2016cited by this paper
• Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.

  2016cited by this paper
• Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction

  2015cited by this paper
• Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease.

  2015cited by this paper
• A systematic review and meta-analysis of longitudinal hippocampal atrophy in healthy human ageing

  2015cited by this paper
• Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients

  2015cited by this paper
• A web-portal for interactive data exploration, visualization, and hypothesis testing

  2014cited by this paper
• Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration

  2014cited by this paper
• Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography.

  2014cited by this paper
• CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

  2014cited by this paper
• Cerebrovascular Biomarker Profile Is Related to White Matter Disease and Ventricular Dilation in a LADIS Substudy

  2014cited by this paper
• Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluid.

  2014cited by this paper
• CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome

  2013cited by this paper
• Brain morphometry reproducibility in multi-center 3 T MRI studies: A comparison of cross-sectional and longitudinal segmentations

  2013cited by this paper
• Brain Changes in Older Adults at Very Low Risk for Alzheimer's Disease

  2013cited by this paper
• Within-subject template estimation for unbiased longitudinal image analysis

  2012cited by this paper
• CSF T-Tau/Aβ42 Predicts White Matter Microstructure in Healthy Adults at Risk for Alzheimer’s Disease

  2012cited by this paper
• Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease.

  2010cited by this paper
• Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

  2010cited by this paper
• Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study.

  2010cited by this paper
• Amyloid- (cid:1) (1– 42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease

  2010cited by this paper
• White Matter Lesions and Brain Atrophy: More than Shared Risk Factors? A Systematic Review

  2009cited by this paper
• Decreased cerebrospinal fluid Aβ42 correlates with brain atrophy in cognitively normal elderly

  2009cited by this paper
• A meta-analysis of hippocampal atrophy rates in Alzheimer's disease.

  2009cited by this paper
• Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models

  2008cited by this paper
• Brain tissue volumes in the general elderly population. The Rotterdam Scan Study.

  2008cited by this paper
• A Systematic Review and Meta-Analysis of CSF Neurofilament Protein Levels as Biomarkers in Dementia

  2007cited by this paper
• Generalized Additive Models: An Introduction With R

  2007cited by this paper
• Neurochemical aftermath of amateur boxing

  2006cited by this paper
• Biological markers in CSF and blood for axonal degeneration in multiple sclerosis.

  2005cited by this paper
• Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss.

  2005cited by this paper
• Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS.

  2004cited by this paper
• Elevated neurofilament levels in neurological diseases.

  2003cited by this paper
• Multiple sclerosis: Neurofilament light chain antibodies are correlated to cerebral atrophy

  2003cited by this paper
• Multiple sclerosis

  2003cited by this paper
• Incidence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study

  2003cited by this paper
• Intracranial arterial dolichoectasia and its relation with atherosclerosis and stroke subtype

  2003cited by this paper
• Neurotechnique Whole Brain Segmentation: Automated Labeling of Neuroanatomical Structures in the Human Brain

  2002cited by this paper
• Prevalence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study

  2002cited by this paper
• Neurofilament protein in cerebrospinal fluid: A marker of white matter changes

  2001cited by this paper
• Standardization of measurement of β-amyloid(1-42) in cerebrospinal fluid and plasma

  2000cited by this paper
• Clock‐drawing: is it the ideal cognitive screening test?

  2000cited by this paper
• Cortical surface-based analysis. I. Segmentation and surface reconstruction.

  1999cited by this paper
• Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF

  1996cited by this paper
• Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease.

  1994cited by this paper
• A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary

  1993cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease

  1989cited by this paper
• Expression of neurofilament subunits in neurons of the central and peripheral nervous system: an immunohistochemical study with monoclonal antibodies

  1986cited by this paper
• The Revised Kendrick Battery: clinical studies.

  1979cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• A new look at the statistical model identification

  1974cited by this paper
• The relation of the trail making test to organic brain damage.

  1955cited by this paper

• Vulnerability to memory decline in aging – a mega-analysis of structural brain change

  2025cites this paper
• The role of plasma inflammatory markers in late-life depression and conversion to dementia: a 3-year follow-up study

  2025cites this paper
• Validation of Spatial Orientation Screening questionnaire for use in memory clinic patients

  2025cites this paper
• Blood level of neurofilament light chain as a biomarker for neurological disorders

  2025cites this paper
• Cerebrospinal Fluid Biomarkers of Alzheimer Disease

  2025cites this paper
• Distinguishing Lifelong Individual Differences from Divergent Aging Trajectories of Adult Brain Volumes

  2025cites this paper
• Association between serum neurofilament light chain levels and grip strength among US adults: a cross-sectional study using National Health and Nutrition Examination Survey data from 2013 to 2014

  2025cites this paper
• Association between serum neurofilament light chain levels and chronic kidney disease: a cross-sectional population-based study from the National Health and Nutrition Examination Survey (2013–2014 cycle)

  2024cites this paper
• Multi-peptide characterization of plasma neurofilament light chain in preclinical and mild Alzheimer’s disease

  2024cites this paper
• Neurofilaments as biomarkers in neurological disorders — towards clinical application

  2024cites this paper
• Introducing neurofilament light chain measure in psychiatry: current evidence, opportunities, and pitfalls

  2024cites this paper
• Subtypes of brain change in aging and their associations with cognition and Alzheimer’s disease biomarkers

  2024cites this paper
• Fluid-based biomarkers in neurodegeneration: Current findings and future directions

  2024cites this paper
• Subtypes of brain change in aging and their associations with cognition and Alzheimer's disease biomarkers.

  2024influential citation
• Neurobiology of Aging

  2023cites this paper
• Blueberry Supplementation Effects on Neuronal and Pathological Biomarkers in Subjects at Risk for Alzheimer’s Disease: A Pilot Study

  2023cites this paper
• How do neurons age? A focused review on the aging of the microtubular cytoskeleton

  2023cites this paper
• Neurofilaments - small proteins of physiological significance and predictive power for future neurodegeneration and cognitive decline across the life span.

  2023cites this paper
• Delirium, neurofilament light chain, and progressive cognitive impairment: analysis of a prospective Norwegian population-based cohort.

  2023cites this paper
• Antibody-Mediated Clearance of Brain Amyloid-β: Mechanisms of Action, Effects of Natural and Monoclonal Anti-Aβ Antibodies, and Downstream Effects

  2023cites this paper
• Matrix metalloproteinases are associated with brain atrophy in cognitively unimpaired individuals.

  2023cites this paper
• Sex-specific associations of matrix metalloproteinases in Alzheimer’s disease

  2023cites this paper
• Associations of neuroinflammatory IL-6 and IL-8 with brain atrophy, memory decline, and core AD biomarkers - In cognitively unimpaired older adults.

  2023influential citation
• Kynurenine Pathway Metabolites in the Blood and Cerebrospinal Fluid Are Associated with Human Aging

  2022cites this paper
• Functional brain activity constrained by structural connectivity reveals cohort-specific features for serum neurofilament light chain

  2022cites this paper
• Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage

  2022cites this paper
• Neurodegeneration and convergent factors contributing to the deterioration of the cytoskeleton in Alzheimer's disease, cerebral ischemia and multiple sclerosis (Review)

  2022cites this paper
• Plasma NfL is associated with mild cognitive decline in patients with diabetes

  2022cites this paper
• Cerebrospinal fluid catecholamines in Alzheimer’s disease patients with and without biological disease

  2022cites this paper
• Relationship between cerebrospinal fluid neurodegeneration biomarkers and temporal brain atrophy in cognitively healthy older adults.

  2022cites this paper
• Combined Effects of Synaptic and Axonal Integrity on Longitudinal Gray Matter Atrophy in Cognitively Unimpaired Adults

  2022cites this paper
• Subtle Differences in Cognition in 70-Year-Olds with Elevated Cerebrospinal Fluid Neurofilament Light and Neurogranin: A H70 Cross-Sectional Study

  2022cites this paper
• The Potential of Neurofilament Light as a Biomarker in Alzheimer’s Disease

  2021cites this paper
• Differential longitudinal changes of neuronal and glial damage markers in anorexia nervosa after partial weight restoration

  2021cites this paper
• Extracellular vesicle concentrations of glial fibrillary acidic protein and neurofilament light measured 1 year after traumatic brain injury

  2021cites this paper
• Relationship of Neurofilament light (NfL) and Cognitive Performance in a Sample of Mexican Americans with Normal Cognition, Mild Cognitive Impairment and Dementia.

  2021cites this paper
• Cerebrospinal Fluid Concentration of Neurogranin in Hip Fracture Patients with Delirium

  2021cites this paper
• Recent advances in pre-clinical diagnosis of Alzheimer’s disease

  2021cites this paper
• Associations of circulating C-reactive proteins, APOE ε4, and brain markers for Alzheimer's disease in healthy samples across the lifespan.

  2021influential citation
• Levels of serum Phosphorylated Neurofilament Heavy subunit in clinically healthy Standardbred horses.

  2021cites this paper
• Biomarkers used in Alzheimer's Disease diagnosis, treatment, and prevention.

  2021cites this paper
• Association between plasma neurofilament light chain levels and cognitive function in patients with Parkinson's disease.

  2021cites this paper
• The Potential Effects of Oxidative Stress-Related Plasma Abnormal Protein Aggregate Levels on Brain Volume and Its Neuropsychiatric Consequences in Parkinson's Disease

  2021cites this paper
• Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies

  2021cites this paper
• Neurofilament Levels in CSF and Serum in an Adult SMA Cohort Treated with Nusinersen

  2021cites this paper
• Utility of Plasma Neurofilament Light in the 1Florida Alzheimer’s Disease Research Center (ADRC)

  2020cites this paper
• Cerebrospinal Fluid Levels of Interleukin-8 in Delirium, Dementia, and Cognitively Healthy Patients

  2020cites this paper
• Contribution of CSF biomarkers to early‐onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures

  2020cites this paper
• Serum neurofilament light levels in normal aging and their association with morphologic brain changes

  2020cites this paper
• Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease

  2020cites this paper
• Biomarker profiling beyond amyloid and tau: cerebrospinal fluid markers, hippocampal atrophy, and memory change in cognitively unimpaired older adults.

  2020cites this paper
• Fatty Acid-Binding Protein 3 in Cerebrospinal Fluid of Hip Fracture Patients with Delirium

  2020cites this paper
• Title: Fatty Acid-Binding Protein 3 in Cerebrospinal Fluid of Hip Fracture Patients with Delirium Authors/affiliations:

  2020cites this paper
• Cerebrospinal fluid sTREM2 in Alzheimer’s disease: comparisons between clinical presentation and AT classification

  2020cites this paper
• Genetic risk for Alzheimer disease predicts hippocampal volume through the human lifespan

  2020cites this paper
• Contributions of Molecular and Optical Techniques to the Clinical Diagnosis of Alzheimer’s Disease

  2020cites this paper
• Delirium

  2020cites this paper
• A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease

  2020cites this paper
• PROSPECTIVE BLOOD-BASED BIOMARKERS OF NEURODEGENERATION

  2020cites this paper
• Neurofilament light in serum and cerebrospinal fluid in hip fracture patients with delirium Authors Halaas NB1,2, Blennow K3,4, Idland AV5,6, Wyller TB5,7, Ræder J7,8, Frihagen F9, Staff

  2019cites this paper
• Self-reported sleep problems are related to amyloid deposition in cortical regions with high HOMER1 gene expression Running title: Sleep, amyloid and HOMER1 gene expression

  2019cites this paper
• Self-reported Sleep Problems Related to Amyloid Deposition in Cortical Regions with High HOMER1 Gene Expression.

  2019cites this paper
• Genome-wide association study of cerebrospinal fluid neurofilament light levels in non-demented elders.

  2019cites this paper
• CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults.

  2019cites this paper
• Postoperative delirium is associated with increased plasma neurofilament light.

  2019cites this paper
• Cerebrospinal fluid and plasma neurofilament light relate to abnormal cognition

  2019cites this paper
• Genetic risk for Alzheimer’s disease predicts hippocampal volume through the lifespan

  2019cites this paper
• Analysis of neurofilament concentration in healthy adult horses and utility in the diagnosis of equine protozoal myeloencephalitis and equine motor neuron disease.

  2019cites this paper
• Delirium and Alzheimer disease: A proposed model for shared pathophysiology

  2019cites this paper
• Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer’s disease pathogenesis

  2019cites this paper
• Neurofilament Light in Serum and Cerebrospinal Fluid of Hip Fracture Patients with Delirium

  2018cites this paper
• Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease

  2018cites this paper
• Neuroinflammation and Tau Interact with Amyloid in Predicting Sleep Problems in Aging Independently of Atrophy

  2018cites this paper
• Neurofilaments as biomarkers in neurological disorders

  2018cites this paper
• Plasma neurofilament light chain levels in Alzheimer's disease.

  2017cites this paper
• In the Pipeline-Alzheimerʼs Disease: Serum Neurofilament Light Levels Linked to Preclinical Changes in Familial Alzheimerʼs Disease

  2017cites this paper
• Tau and neurodegeneration : neuroimaging, genes, and biomarkers

  2017cites this paper
• New cerebrospinal fluid biomarkers in Alzheimer’s disease

  2017cites this paper
• A blood-based signature of neocortical amyloid burden : an early diagnostic population screening tool for Alzheimer's disease

  2017cites this paper
• Brain parenchymal fraction in healthy individuals and in clinical follow-up of multiple sclerosis

  2016cites this paper
• Cerebrospinal fluid neurofilament light chain is a marker of aging Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage and white matter damage

  year unknowncites this paper